This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Feb;14(2):102-3.

doi: 10.1016/S1470-2045(12)70581-8. Epub 2013 Jan 9.

A prognostic model for metastatic renal-cell carcinoma

Matthew D Galsky¹

Affiliations

PMID: 23312462
DOI: 10.1016/S1470-2045(12)70581-8

Comment

A prognostic model for metastatic renal-cell carcinoma

Matthew D Galsky. Lancet Oncol. 2013 Feb.

. 2013 Feb;14(2):102-3.

doi: 10.1016/S1470-2045(12)70581-8. Epub 2013 Jan 9.

Author

Matthew D Galsky¹

Affiliation

¹ Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY 10029, USA. matthew.galsky@mssm.edu

PMID: 23312462
DOI: 10.1016/S1470-2045(12)70581-8

No abstract available

PubMed Disclaimer

Comment on

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study.
Heng DY, Xie W, Regan MM, Harshman LC, Bjarnason GA, Vaishampayan UN, Mackenzie M, Wood L, Donskov F, Tan MH, Rha SY, Agarwal N, Kollmannsberger C, Rini BI, Choueiri TK. Heng DY, et al. Lancet Oncol. 2013 Feb;14(2):141-8. doi: 10.1016/S1470-2045(12)70559-4. Epub 2013 Jan 9. Lancet Oncol. 2013. PMID: 23312463 Free PMC article.

Similar articles

Re: Renal cell carcinoma: prognostic significance of incidentally detected tumors.
Luciani LG. Luciani LG. J Urol. 2001 Apr;165(4):1223. J Urol. 2001. PMID: 11257686 No abstract available.
Prognostic factors for survival in metastatic renal cell carcinoma: update 2008.
Bukowski RM. Bukowski RM. Cancer. 2009 May 15;115(10 Suppl):2273-81. doi: 10.1002/cncr.24226. Cancer. 2009. PMID: 19402065 Review.
Incidental detection of renal cell carcinoma is an independent prognostic marker: results of a long-term, whole population study.
Palsdottir HB, Hardarson S, Petursdottir V, Jonsson A, Jonsson E, Sigurdsson MI, Einarsson GV, Gudbjartsson T. Palsdottir HB, et al. J Urol. 2012 Jan;187(1):48-53. doi: 10.1016/j.juro.2011.09.025. Epub 2011 Nov 16. J Urol. 2012. PMID: 22088336
Prognosis of renal cell carcinoma.
Bahnson R. Bahnson R. J Urol. 2007 Apr;177(4):1224. doi: 10.1016/j.juro.2007.01.024. J Urol. 2007. PMID: 17382693 No abstract available.
Prognostic factors and molecular markers for renal cell carcinoma.
Bui MH, Zisman A, Pantuck AJ, Han KR, Wieder J, Belldegrun AS. Bui MH, et al. Expert Rev Anticancer Ther. 2001 Dec;1(4):565-75. doi: 10.1586/14737140.1.4.565. Expert Rev Anticancer Ther. 2001. PMID: 12113089 Review.

See all similar articles

Cited by

The presence of tumour-infiltrating neutrophils is an independent adverse prognostic feature in clear cell renal cell carcinoma.
Tessier-Cloutier B, Twa DD, Marzban M, Kalina J, Chun HE, Pavey N, Tanweer Z, Katz RL, Lum JJ, Salina D. Tessier-Cloutier B, et al. J Pathol Clin Res. 2021 Jul;7(4):385-396. doi: 10.1002/cjp2.204. Epub 2021 Mar 4. J Pathol Clin Res. 2021. PMID: 33665979 Free PMC article.
Improving outcomes in high-risk, nonmetastatic renal cancer: new data and ongoing trials.
Blick C, Ritchie AWS, Eisen T, Stewart GD. Blick C, et al. Nat Rev Urol. 2017 Dec;14(12):753-759. doi: 10.1038/nrurol.2017.123. Epub 2017 Aug 1. Nat Rev Urol. 2017. PMID: 28762388 Review.
DNA methylation biomarkers predict progression-free and overall survival of metastatic renal cell cancer (mRCC) treated with antiangiogenic therapies.
Peters I, Dubrowinskaja N, Abbas M, Seidel C, Kogosov M, Scherer R, Gebauer K, Merseburger AS, Kuczyk MA, Grünwald V, Serth J. Peters I, et al. PLoS One. 2014 Mar 14;9(3):e91440. doi: 10.1371/journal.pone.0091440. eCollection 2014. PLoS One. 2014. PMID: 24633192 Free PMC article.
Prognostic factors and prognostic models for renal cell carcinoma: a literature review.
Klatte T, Rossi SH, Stewart GD. Klatte T, et al. World J Urol. 2018 Dec;36(12):1943-1952. doi: 10.1007/s00345-018-2309-4. Epub 2018 Apr 30. World J Urol. 2018. PMID: 29713755 Review.
Patient's self-reported quality of life as a prognostic factor in metastatic renal cell carcinoma initially treated with TKI: nomogram proposal.
Lendínez-Cano G, Vilches-Arenas Á, Congregado-Ruíz B, Medina-López R. Lendínez-Cano G, et al. World J Urol. 2024 Apr 27;42(1):267. doi: 10.1007/s00345-024-04972-9. World J Urol. 2024. PMID: 38678165

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information